Year Established :
1992
Total Assets(USD) :
choose not to disclose
Total Number of Staff :
less than 10 person
Main Competitive Advantages :
Brandname,Experienced R&D Staff,Delivery Term,Production capacity,Large Product Line,Buyers Specifications Accepted,Small Orders Accepted,Reputation,Quality Service
Other Competitive Advantages :
Core competitiveness
1. The enterprise undertakes creation of the national major new drug and developes a first class new drugs DHMEQ
2.Orally disintegrating technology is in the lead in China and in the world
3.Multi-layer dropping pill technology is initiative in China, and is in the lead in the world
4.Top-ranking professional marketing team focus on digestive, hepatic and renal diseases
5.Rich resources of medicine and medical specialists is built upon over thirty year’s close cooperation and sincerity
6.Profound international partners are established upon over sixty year’s mutual trust and beneficial cooperation
7.The enterprise established the Shenzhen Enterprise Technology Center, and carry out industrial-academic-researches join with domestic and foreign universities and scientific institutions
Patents and Copyrights :
31 authorized patents
Business Type :
Manufacturer,Agent,Trading Company
R&D Capacity :
Own brand
Annual Turnover(USD) :
choose not to disclose
Main Sales Markets :
Eastern Europe,Asia
Main Product Categorise :
Finished Dosage
Product Range :
Compound Amino Acids Capsules（8-11）
Polyethylene Glycol Electrolytes Powder
Erythromycin Enteric-coated Capsules
Compound Amino Acid Granules（9AA)
Levofloxacin Hydrochloride Ear Drop
One year of qualification
Audited Supplier
Pharma Sources Insight JANUARY 2024
